🚀 VC round data is live in beta, check it out!
HeartBeam Valuation Multiples
Discover revenue and EBITDA valuation multiples for HeartBeam and similar public comparables like OssDsign, MeVis, Mach7 Technologies, Elutia and more.
HeartBeam Overview
About HeartBeam
HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company’s ability to develop higher-resolution ECG solutions is achieved through the development of the Company’s proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
Founded
2015
HQ
Employees
21
Website
Financials (LTM)
EV
$45M
HeartBeam Financials
HeartBeam reported last 12-month revenue of $585K and negative EBITDA of ($23M).
In the same LTM period, HeartBeam generated $395K in gross profit, ($23M) in EBITDA losses, and had net loss of ($21M).
Revenue (LTM)
HeartBeam P&L
In the most recent fiscal year, HeartBeam reported revenue of — and EBITDA of ($21M).
HeartBeam expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $585K | XXX | — | XXX | XXX | XXX |
| Gross Profit | $395K | XXX | — | XXX | XXX | XXX |
| Gross Margin | 68% | XXX | — | XXX | XXX | XXX |
| EBITDA | ($23M) | XXX | ($21M) | XXX | XXX | XXX |
| EBITDA Margin | (3882%) | XXX | — | XXX | XXX | XXX |
| EBIT Margin | (3693%) | XXX | — | XXX | XXX | XXX |
| Net Profit | ($21M) | XXX | ($21M) | XXX | XXX | XXX |
| Net Margin | (3659%) | XXX | — | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
HeartBeam Stock Performance
HeartBeam has current market cap of $49M, and enterprise value of $45M.
Market Cap Evolution
HeartBeam's stock price is $0.92.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $45M | $49M | 0.0% | XXX | XXX | XXX | $-0.39 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialHeartBeam Valuation Multiples
HeartBeam trades at 76.8x EV/Revenue multiple, and (2.0x) EV/EBITDA.
EV / Revenue (LTM)
HeartBeam Financial Valuation Multiples
As of April 20, 2026, HeartBeam has market cap of $49M and EV of $45M.
Equity research analysts estimate HeartBeam's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
HeartBeam has a P/E ratio of (2.3x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $49M | XXX | $49M | XXX | XXX | XXX |
| EV (current) | $45M | XXX | $45M | XXX | XXX | XXX |
| EV/Revenue | 76.8x | XXX | — | XXX | XXX | XXX |
| EV/EBITDA | (2.0x) | XXX | (2.1x) | XXX | XXX | XXX |
| EV/EBIT | (2.1x) | XXX | (2.1x) | XXX | XXX | XXX |
| EV/Gross Profit | 113.7x | XXX | — | XXX | XXX | XXX |
| P/E | (2.3x) | XXX | (2.3x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (3.1x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified HeartBeam Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
HeartBeam Margins & Growth Rates
HeartBeam's revenue in the last 12 month grew by 545%.
HeartBeam's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $1.0M for the same period.
HeartBeam Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 545% | XXX | — | XXX | XXX | XXX |
| EBITDA Margin | (3882%) | XXX | — | XXX | XXX | XXX |
| EBITDA Growth | 18% | XXX | 26% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $1.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 240% | XXX | — | XXX | XXX | XXX |
| G&A Expenses to Revenue | 1379% | XXX | — | XXX | XXX | XXX |
| R&D Expenses to Revenue | 2266% | XXX | — | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
HeartBeam Public Comps
See public comps and valuation multiples for other Medical Devices and Medical Imaging & Diagnostics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| HeartBeam | XXX | XXX | XXX | XXX | XXX | XXX |
| OssDsign | XXX | XXX | XXX | XXX | XXX | XXX |
| MeVis | XXX | XXX | XXX | XXX | XXX | XXX |
| Mach7 Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| Elutia | XXX | XXX | XXX | XXX | XXX | XXX |
| INIFY Laboratories | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
HeartBeam M&A Activity
HeartBeam acquired XXX companies to date.
Last acquisition by HeartBeam was on XXXXXXXX, XXXXX. HeartBeam acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by HeartBeam
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialHeartBeam Investment Activity
HeartBeam invested in XXX companies to date.
HeartBeam made its latest investment on XXXXXXXX, XXXXX. HeartBeam invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by HeartBeam
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout HeartBeam
| When was HeartBeam founded? | HeartBeam was founded in 2015. |
| Where is HeartBeam headquartered? | HeartBeam is headquartered in United States. |
| How many employees does HeartBeam have? | As of today, HeartBeam has over 21 employees. |
| Who is the CEO of HeartBeam? | HeartBeam's CEO is Robert P. Eno. |
| Is HeartBeam publicly listed? | Yes, HeartBeam is a public company listed on Nasdaq. |
| What is the stock symbol of HeartBeam? | HeartBeam trades under BEAT ticker. |
| When did HeartBeam go public? | HeartBeam went public in 2021. |
| Who are competitors of HeartBeam? | HeartBeam main competitors are OssDsign, MeVis, Mach7 Technologies, Elutia. |
| What is the current market cap of HeartBeam? | HeartBeam's current market cap is $49M. |
| What is the current revenue of HeartBeam? | HeartBeam's last 12 months revenue is $585K. |
| What is the current revenue growth of HeartBeam? | HeartBeam revenue growth (NTM/LTM) is 545%. |
| What is the current EV/Revenue multiple of HeartBeam? | Current revenue multiple of HeartBeam is 76.8x. |
| Is HeartBeam profitable? | No, HeartBeam is not profitable. |
| What is the current EBITDA of HeartBeam? | HeartBeam has negative EBITDA and is not profitable. |
| What is HeartBeam's EBITDA margin? | HeartBeam's last 12 months EBITDA margin is (3882%). |
| What is the current EV/EBITDA multiple of HeartBeam? | Current EBITDA multiple of HeartBeam is (2.0x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.